β--Diphosphopyridine nucleotide(β-NAD)
| Post Date: |
Dec 20,2021 |
| Expiry Date: |
Jun 18,2022 |
| Detailed Description: |
Cas No. :53-84-9
|
| CAS Registry Number: |
|
| Synonyms: |
;nadide;beta-Diphosphopyridine nucleotide;cozymase;beta-dpn;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] phosphate;NAD;beta-Nicotinamide adenine dinucleotide trihydrate;β-Nicotinamide Adenine Dinuclotide;β-Nicotinamide adenine dinucleotide;NAD+; |
| Molecular Formula: |
C21H26N7O14P2 |
| Molecular Weight: |
662.4177 |
| Molecular Structure: |
|
| Safety Description: |
S24/25:Avoid contact with skin and eyes.;
|
| Company: |
H&B Pharm-Tech Co.,Ltd.
[ China ]
|
| Contact: |
Jackie Chan |
| Tel: |
+86 189 5415 5098 |
| Fax: |
info@hbpharmtech.com |
| Email: |
info@hbpharmtech.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
